During the past decade, Centro Digestivo de Curitiba conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Digestivo de Curitiba" are "Ulcerative Colitis" (3 trials), "Crohn Disease" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Centro Digestivo de Curitiba" in a lesser frequency.

Most popular intervention types in "Centro Digestivo de Curitiba" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (5 trials), "Placebo" (3 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Etrolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Digestivo de Curitiba" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centro Digestivo de Curitiba". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Digestivo de Curitiba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Digestivo de Curitiba, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".